Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Therapeutic Drug Monitoring|October 1, 1996
Blood concentrations and clinical effect of cyclosporin in psoriasisM Furlanut, M Baraldo, F Pea, et al.Therapeutic Drug Monitoring|August 15, 2000
Ciprofloxacin disposition in elderly patients with LRTI being treated with sequential therapy (200 mg intravenously twice daily followed by 500 mg per os twice daily): comparative pharmacokinetics and the role of therapeutic drug monitoringF Pea, R Milaneschi, M Baraldo, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2001
Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitisP G Scotton, F Pea, M Giobbia, et al.Epilepsia|May 14, 1998
Oral gabapentin disposition in patients with epilepsy after a high-protein mealP Benetello, M Furlanut, M Fortunato, et al.Journal of Global Antimicrobial Resistance|November 28, 2016
Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment optionsS M Purrello, J Garau, E Giamarellos, et al.Journal of Chemotherapy (Florence, Italy)|March 5, 2004
Urinary pharmacokinetics and theoretical pharmacodynamics of intravenous levofloxacin in intensive care unit patients treated with 500 mg b.i.d. for ventilator-associated pneumoniaF Pea, F Pavan, E Di Qual, et al.Cancer Chemotherapy and Pharmacology|October 29, 2000
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemiaF Pea, D Russo, M Michieli, et al.Biomaterials|December 1, 1993
Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in ratsL Benedetti, R Cortivo, T Berti, et al.European Journal of Clinical Pharmacology|August 24, 1999
Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemiaF Pea, D Damiani, M Michieli, et al.British Journal of Haematology|August 12, 1999
Liposome-encapsulated daunorubicin for PGP-related multidrug resistanceM Michieli, D Damiani, A Ermacora, et al.Pageof 4